The invasiveness of cancer cells resembles the normal behavior of cells that migrate into surrounding tissues during development. For example, the border cells in the Drosophila ovary undergo a partial epithelial to mesenchymal transition and invade the neighboring cluster of germline cells, migrating to the oocyte border. Once there, they provide patterning information to the oocyte and produce an eggshell specialization known as the micropyle. Border cell migration has been subjected to extensive genetic analyses using a variety of screening approaches. Recent ®ndings demonstrate that conversion of the border cells from a stationary group of epithelial cells to invasive cells requires integration of the activities of at least two transcriptional regulatory pathways. One such pathway requires the slbo gene, which encodes Drosophila C/EBP, a basic region/leucine zipper transcriptional activator that is required for elevated expression of a number of downstream targets, including DE-cadherin and focal adhesion kinase (FAK). An independent pathway requires the activity of the ecdysone receptor and a recently identi®ed co-activator for the ecdysone receptor known as Taiman (abbreviated TAI, pronounced ti-maan', meaning too slow). Ecdysone is produced in the Drosophila ovary in response to adequate nutrition and is required for progression of oogenesis through stage 9, when border cell migration occurs. Border cells mutant for tai accumulate abnormally high levels of adhesion complexes at their surfaces, which may account for their inability to migrate. Thus border cell migration requires a differentiation program mediated by the C/EBP pathway, which is required for elevated expression of a number of proteins required for motility. In addition, migration requires a hormonal signal that relays information regarding nutritional status and appears to be required for regulation of the proper localization of some of the C/EBP targets. These ®ndings suggest that steroid hormones can regulate cell motility relatively directly, independent of the effects on proliferation. This may contribute to the metastatic effects of steroid hormones on certain cancers and the inhibition of metastasis by steroid hormone antagonists such as tamoxifen. q
Invasion of the border cells
The border cells in the Drosophila ovary originate within an epithelium of approximately 650 epithelial cells known as follicle cells in a structure called an egg chamber (Fig. 1) . One pair of specialized follicle cells, known as polar cells, differentiates at each pole of the egg chamber. The anterior polar cells recruit four to eight additional cells to surround them, forming the border cell cluster. The polar cells are not themselves migratory (Han et al., 2000) , rather the surrounding cells carry the polar cells through the nurse cell cluster to the anterior border of the oocyte. The border cells perform at least two essential functions during oogenesis. They participate in forming the micropyle, which is an eggshell structure required for sperm entry . In addition, the border cells, as well as some posterior follicle cells, express the torso-like gene (Savant-Bhonsale and Montell, 1993) , which is an essential patterning signal required to specify appropriate cell fates at the extreme anterior and posterior ends of the egg and embryo (Stevens et al., 1990) .
As the border cells initiate migration, they undergo a morphological change that resembles an epithelial to mesenchymal transition. Prior to migration, the border cells form a continuous epithelium with the other follicle cells, maintaining adherens junctions with the neighboring cells. In addition, they exhibit polarized localization of Crumbs, an apical marker in epithelial cells (Niewiadomska et al., 1999) . At the time of migration, the cells break free of neighboring follicle cells, extend actin-rich ®lopodia, and acquire an extended, irregular, ®broblast-like morphology (Fig. 1) . In addition, they lose polarization of Crumbs protein localization (Niewiadomska et al., 1999) . The central polar cells, however, retain epithelial polarity, remain in the center of the cluster, and do not actively migrate.
The border cells do not lose all epithelial characteristics as they migrate. In fact, they remain attached to each other and to the central polar cells via junctions that contain Ecadherin and Drosophila beta-catenin (which is known as armadillo, ARM) (Niewiadomska et al., 1999) . The junctions between border cells appear epithelial in character while the interface between the border cells and the nurse cells appears mesenchymal. Therefore, a complete loss of epithelial characteristics is not necessarily required for cells to become motile.
The conversion of a stationary, epithelial cell to an invasive, motile cell undoubtedly requires changes in gene expression, cell adhesion, and cytoskeletal organization. However, the biochemical basis of this process is not well understood. In order to gain a more complete understanding of border cell behavior, several different types of genetic screens have been conducted. Testing of speci®c candidate genes has also been carried out. All of these approaches have shed light on the factors controlling border cell invasive behavior and many of the puzzle pieces are beginning to ®t together into a coherent picture.
SLBO commands invasion by marshalling an army of downstream targets
Although cell migration could conceivably proceed by dynamic reorganization of proteins pre-existing in the epithelial cell, this does not appear to be the case. Rather, extensive changes in gene expression are essential for the border cells to acquire their invasive phenotype. The ®rst gene identi®ed to play a role in border cell migration was slow border cells (slbo), which was identi®ed in a screen for P-element induced female sterility . The slbo locus encodes the Drosophila homolog of C/ EBP, a basic region/leucine zipper transcriptional activator Rùrth and Montell, 1992) . The ®nding that border cell migration requires Drosophila C/EBP implied that one or more transcriptional targets of C/EBP would encode a protein essential for migration.
A number of downstream targets of C/EBP have been identi®ed, some of which are clearly essential for border cell migration. In particular, the homophilic cell±cell adhesion molecule DE-cadherin is expressed at elevated levels in migrating border cells and this elevation fails to occur in slbo mutants (Niewiadomska et al., 1999) . Moreover, loss of E-cadherin alone, in either the border cells or the nurse cells, results in failure of border cell invasion (Oda et al., 1997; Niewiadomska et al., 1999) . Presumably, the role of Ecadherin in migration is to provide suf®cient traction to allow the border cells to grip the nurse cell surfaces upon which they are migrating. However, the ®nding of a role for E-cadherin in promoting cell migration was somewhat surprising. Although N-cadherin has been shown to promote cell motility in a variety of biological contexts, E-cadherin has been widely reported to promote epithelial morphology and inhibit invasive behavior (see, for example, Takeichi, 1993) . A resolution of this apparent paradox is that different cell types appear to respond differently to increased E-cadherin expression. In some cell types, such as human ovarian carcinoma cells (Ong et al., 2000) and border cells, elevated expression of E-cadherin promotes cell motility, while in many other cell types E-cadherin inhibits cell motility. The basis for this difference may lie in how ef®ciently different cell types turn over adhesion complexes. In stationary epithelial cells, adherens junctions are very stable, whereas in cells that lack stable adhesions, such as subconuent cultured cells, E-cadherin is recycled through the endocytic pathway at a rapid rate (Le et al., 1999) . In migrating cells, adhesion with the substrate is necessarily transient. Some regulatory mechanism must exist to promote the rapid recycling and/or turnover of adhesion complexes in migratory cells but not in stationary cells.
One protein implicated in turnover of focal adhesions in cultured cells is the cytoplasmic tyrosine kinase, called focal adhesion kinase (FAK). FAK plays a key role in promoting cell motility since cells isolated from mice homozygous for a targeted deletion of FAK migrate poorly (Ilic et al., 1995) . In addition, their slower migration appears to result from abnormal accumulation of focal adhesions. In other words, the mutant cells become stuck. Thus FAK has been proposed to stimulate motility by promoting rapid turnover of focal adhesions. Recently, FAK has been discovered to be highly expressed in migrating border cells (Fox et al., 1999) and to be a downstream target of C/EBP (Bai et al., 2001) . It is likely then that FAK contributes to border cell migration. However, loss-of-function mutations in Drosophila FAK have not yet been identi®ed.
The FGF receptor encoded by the breathless (btl) locus appears to be expressed in border cells and dependent upon C/EBP. In addition, over-expression of btl can restore migration in weak slbo mutants (Murphy et al., 1995) . BTL plays a key role in chemotactic guidance of tracheal cell migration in the Drosophila embryo (Lee et al., 1996; Sutherland et al., 1996) ; however, loss-of-function mutations in btl do not cause any obvious defect in border cell migration (Murphy et al., 1995) . Nor does over-expression of the ligand, Branchless, impede border cell migration (Rùrth, 1998) . Thus it is unclear what role, if any, btl plays in border cell migration.
A fourth target of C/EBP has been identi®ed recently. The jing (which means`still') locus was identi®ed in a screen for mutations that cause border cell migration defects in mosaic clones (Liu and Montell, 1999) . Mosaic clones are patches of homozygous mutant cells within an otherwise heterozygous organism. Thus even if a mutation is homozygous lethal, its function can be analyzed in the border cells by inducing mosaic clones speci®cally in follicle cells. The animal survives because it is heterozygous for the lethal mutation, but the loss-of-function phenotype can be analyzed in homozygous mutant border cells. Like slbo, jing mutant border cells fail to migrate and exhibit reduced expression of a border cell enhancer trap marker known as PZ6356. Moreover, jing appears to be expressed in the border cells, consistent with the cell autonomous requirement for this locus in border cell migration. Border cell expression of jing is undetectable in a slbo mutant background, indicating that jing is a downstream target of slbo. The jing locus encodes a nuclear protein with three zinc ®nger motifs near the C-terminus. The most highly related protein is a mouse protein known as AEBP2, which was identi®ed in a screen for proteins that bind to the same enhancer region as C/EBP in the adipocyte gene AP2. Thus C/EBP and JING might cooperate to regulate the expression of common downstream targets in border cell migration (Liu and Montell, 2001) .
One of the targets that might be regulated coordinately by C/EBP and JING is DE-cadherin. Since jing is a downstream target of C/EBP, expression of both slbo and jing is reduced in slbo mutants, and DE-cadherin expression is dramatically affected. However, in border cells lacking only JING, DE-cadherin expression is not altered from wild-type (Liu and Montell, 2001 ). Based on this ®nding, it might be tempting to conclude that JING does not regulate DEcadherin. However, in a hypomorphic slbo mutant background, in which expression of both slbo and jing is reduced, over-expression of jing alone is suf®cient to restore DE-cadherin expression and border cell migration. Overexpression of jing does not rescue the slbo null phenotype, indicating that JING cannot fully substitute for C/EBP. All of these ®ndings are consistent with the proposal that JING and C/EBP cooperate to enhance the expression of common downstream target genes.
It is unlikely that JING and C/EBP need to bind directly to each other to carry out their functions. This conclusion is based on extensive mutagenesis studies of C/EBP. Speci®-cally, expression of a chimeric protein composed of the C/ EBP DNA-binding domain fused to heterologous transactivation and leucine zipper domains was capable of rescuinḡ ies lacking endogenous C/EBP (Rùrth, 1994) . Presumably, the heterologous transactivation and leucine zipper domains would not engage in any speci®c protein±protein interac-tions that might normally occur with the corresponding domains in C/EBP. Since the chimeric protein appeared to be as functional as the normal C/EPB protein, it is unlikely that C/EBP requires any speci®c, direct interaction with another protein to carry out its function.
The targets of C/EBP described here probably do not constitute the complete set of genes regulated by slbo. In fact recent, unpublished studies from my laboratory have identi®ed another target for C/EBP. Thus it seems that the role of C/EBP in border cell migration is to up-regulate the expression of numerous target genes. Apparently, migration cannot proceed simply by dynamically reorganizing the proteins that were present in the epithelial cells prior to migration. Rather, new gene expression is required.
The precise concentration of C/EBP appears to be critical to its function since either reducing or increasing its expression impedes border cell migration (Rùrth et al., 2000) . The level of C/EBP in border cells appears to be regulated by ubiquitination and proteosome-dependent degradation. Over-expression of a ubiquitin hydrolase, which removes ubiquitin moieties from proteins, has been found to stabilize C/EBP protein, suppressing the migration defect in weak slbo mutants. Conversely, the protein encoded by the tribbles locus appears to target C/EBP for degradation, as overexpression of tribbles causes a reduction in C/EBP protein level and loss of tribbles causes a slight increase in C/EBP protein level.
It is unclear whether the harmful effects of increasing C/ EBP levels are due to increased expression of normal target genes or due to activation of expression of genes not normally regulated by C/EBP (Rùrth et al., 2000) . C/EBP proteins are not exquisitely sequence-speci®c DNA-binding proteins. Thus it is possible that, when over-expressed, C/ EBP binds to suboptimal sites and activates expression of genes that would not be affected by normal C/EBP levels. Alternatively, excessive activation of its normal targets may contribute to the migration delays caused by over-expression of C/EBP. A third possibility is that, at high concentrations, C/EBP represses transcription of target genes that are activated by lower concentrations of C/EBP. Precisely, this type of effect has been reported for the regulation of the gap gene Kruppel (Kr) by the Hunchback (Hb) transcription factor. At high concentrations, Hb represses Kr transcription whereas at slightly lower concentrations, Hb is an essential activator of Kr expression (Hulskamp et al.,1990) . Further studies will be required to clarify how over-expression of C/ EBP leads to a migration defect.
Expression of SLBO, while essential for motility, is not suf®cient to convert other follicle cells to invasive cells. Ectopic slbo expression does not cause extra cells to migrate and early induction of slbo expression is insuf®cient to cause precocious border cell migration. Nor can border cell migration occur signi®cantly later than normal. That is, if slbo expression is induced in slbo mutant egg chambers, border cell migration is restored but only during stages 9 and 10A. Egg chambers that are in stage 10B or later at the time that C/EBP expression is restored do not support border cell migration (D. Montell, unpublished observation). These ®ndings suggest that additional factor(s) are required for border cell migration, which are only present in stages 9 and 10A. A clue as to the identity of one such factor emerged from studies of a second locus that was identi®ed by screening for mutations affecting border cell migration in mosaic clones.
Warring factions ± slbo-independent control of border cell invasion by ecdysone
The tai locus was identi®ed in a screen for mutations on the left arm of the second chromosome that cause border cell migration defects (Bai et al., 2001) . Unlike slbo mutants, border cells mutant for tai show no reduction in expression of C/EBP or PZ6356. Nor do they show reduced expression of DE-cadherin or FAK. Instead, tai mutant border cells exhibit abnormal accumulation of DE-cadherin and ARM at the interface between border cells and nurse cells, suggesting a defect in rapid turnover of adhesion complexes that might be responsible for the migration defect.
The tai locus encodes a protein related to steroid hormone receptor co-activators of the p160 class (Bai et al., 2001 ). Co-activators interact with steroid hormone receptors in a ligand-dependent manner and potentiate hormone-dependent transcriptional activation. The p160 class of co-activators was declared to be missing from Drosophila and C. elegans based on homology searching of the complete genome sequences (Rubin et al., 2000) . Yet the predicted TAI protein clearly contains all of the domains characteristic of p160 co-activators, including a bHLH domain, a PAS domain, LXXLL motifs and glutamine-rich transactivation domains. Moreover, the TAI protein interacts directly with the Drosophila ecdysone receptor in a hormone-dependent manner in vitro and potentiates transcriptional activation of a target reporter gene by the ecdysone receptor in a dose-and hormone-dependent fashion.
TAI protein co-localizes with both subunits of the ecdysone receptor, EcR and USP, at speci®c loci on chromosomes indicating that the three proteins associate in vivo (Bai et al., 2001 ). The interactions of TAI with the ecdysone receptor and the observation that EcR, USP, and TAI are expressed in border cells suggest that border cell migration might be responsive to ecdysone.
If border cell migration requires ecdysone, then mutations in either subunit of the ecdysone receptor ought to cause cell autonomous defects in border cell migration. Indeed, border cells lacking USP fail to migrate. The chromosomal location of the locus coding for EcR prevents mosaic analysis of its function in border cells. However, additional evidence that border cell migration requires ecdysone came from studies of another mutant, ecd 1 , which is temperature-sensitive for ecdysone production. Under certain temperature shift regi-mens, ovaries from ecd 1 mutant¯ies produce stage 10 egg chambers that exhibit speci®c delay of border cell migration (Bai et al., 2001) .
The ®nding that ecdysone signaling is required to promote border cell migration is, in hindsight perhaps, not surprising because it has been known for some time that, in ies just as in humans, reproduction depends upon steroid hormones. In particular, the ovary is a major site for ecdysone synthesis, ecdysone levels are highest during stages 9 and 10, and egg chambers de®cient in ecdysone or ecdysone receptor arrest in late stage 8 or early stage 9 (reviewed in Riddiford, 1993) . Thus it appears that ecdysone signaling coordinates multiple events occurring at stage 9 of oogenesis, including border cell migration. The reason for this appears to be to coordinate egg production with adequate nutrition. This idea stems from previous studies showing that newly eclosed females fail to produce stage 9 or older egg chambers until they are fed a rich diet. Ecdysone is produced in the ovary in response to feeding and fails to be produced in starved females. Injection of juvenile hormone into females stimulates ecdysone production, bypassing the normal nutritional requirement.
TAI functions independently of C/EBP in the control of border cell migration. TAI expression is normal in slbo mutants and C/EBP expression is normal in tai mutants (Bai et al., 2001) . Moreover, over-expression of TAI fails to rescue even weak alleles of slbo and over-expression of C/EBP fails to rescue tai migration defects. Therefore, border cell migration seems to require the integration of these two distinct transcriptional regulatory pathways. Indeed, precocious border cell migration has been observed in egg chambers that both expressed C/EBP precociously and were exposed to ecdysone earlier than normal. However, precocious migration only occurred in a small fraction of such egg chambers, suggesting that yet additional regulatory pathways that have not yet been identi®ed may be required for optimal migration.
The power to invade
Muscle contraction is powered by myosin and it seemed likely that cell motility would also require the power of one or more myosins. Edwards and Kiehart (1996) tested this hypothesis directly, in vivo, by determining whether loss of non-muscle myosin II would affect border cell migration. Non-muscle myosin II is composed of a heavy chain, which is encoded by a locus known as zipper (zip) in Drosophila (Young et al., 1993 ) and a regulatory light chain, which is encoded by a locus known as spaghetti squash (sqh) (Karess et al., 1991) . Mutations in either zip or sqh are lethal. It should be dif®cult or impossible to generate mosaic clones for either mutation because non-muscle myosin II function is required for cytokinesis (Karess et al., 1991) . Thus homozygous mutant cells would be expected to fail to divide. However, homozygous sqh mutant animals can be rescued to adulthood if they harbor a transgene expressing the wildtype sqh gene under the control of a heat-inducible promoter, provided that daily heat shocks are given (Edwards and Kiehart, 1996) . They reported that in these rescued adults, following withdrawal of heat shocks after homozygous sqh 1 females emerged, a number of defects in oogenesis ensue, including failure of border cell migration.
The precise role of myosin in border cell migration is not yet clear. Myosin protein accumulates both at the leading and trailing edges of the cells and so it is possible that myosin promotes the retraction of poorly adherent ®lopodia or lamellipodia and/or that myosin-mediated contraction facilitates forward progress of the cell by loosening adhesive contacts at the rear of the cell.
There are many additional genes coding for a variety of putative myosin motor proteins in the Drosophila genome. It will be of interest to know if some of these are also required to generate the forces necessary for forward movement.
Maneuvers at the advancing front
Small GTPases of the Rho family, such as Rac, Rho, and Cdc42, are known for their roles in generating and maintaining cell polarity in yeast (Johnson, 1999) and for their ability to stimulate reorganization of the actin cytoskeleton in response to extracellular signals (reviewed in Nobes and Hall, 1994; Bishop and Hall, 2000; Schmitz et al., 2000) . In addition, these proteins are evolutionarily well conserved. Therefore, the Rho family seems like excellent candidates for mediating cell migration, a process that clearly requires dynamic reorganization of the actin cytoskeleton in response to extracellular signals. To test this hypothesis in vivo, Murphy and Montell (1996) expressed dominantnegative forms of Rac, Cdc42, and a novel family member RhoL, speci®cally in the border cells. Border cell migration was dramatically and speci®cally inhibited by dominantnegative Rac. Expression of a constitutively active form of Rac also inhibits border cell migration (E. Fields and D. Montell, unpublished) suggesting that cycling between the GTP-bound active state and the GDP-bound inactive state is a critical feature of the role of Rac in motility.
Activated Rac has many effects on mammalian cells including immediate changes to the actin cytoskeleton as well as delayed effects on transcription. Many proteins that interact with Rac have been identi®ed in a variety of organisms (reviewed in Bishop and Hall, 2000) . These include various GTP exchange factors, which activate the proteins, and GTPase activating proteins, which stimulate hydrolysis of GTP, inactivating the proteins. Serine/threonine kinases such as PAK, which interact speci®cally with the GTP-bound forms of Rac and Cdc42, are thought to mediate some of their biological effects. However, the biochemical events leading from activation of Rac to reorganization of the actin cytoskeleton remain largely unclear.
Identi®cation of additional genes and gene products that function with Rac to control border cell migration may eventually shed some light on this issue.
Another protein that is likely to regulate actin dynamics in the migrating border cells is ADF/co®lin. ADF stands for actin depolymerizing factor and is thought to be important for the dynamic treadmilling of actin that must occur in translocating cells. Recently, mutations in a gene named twinstar were identi®ed, which caused a partially penetrant defect in border cell migration, among other things. The twinstar gene encodes a protein with very signi®cant homology to ADF/co®lin (Chen et al., 2001) .
The end game
Once the border cells reach the oocyte border, they undergo a second, small displacement towards the dorsal side of the egg chamber and align themselves with the oocyte nucleus. Not surprisingly, this displacement depends upon proper dorsal/ventral patterning of the egg chamber, a process that is dependent upon the TGF-a-like protein Gurken and the Drosophila EGF receptor homolog (Duchek and Rùrth, 2001 ). This phase of border cell migration may respond directly to Gurken since cell autonomous loss of EGF receptor function prevents the alignment of the border cells with the oocyte nucleus (Duchek and Rùrth, 2001 ).
Border cell migration as a model for tumor metastasis
Studies of border cell migration to date suggest that it is a valid model for the study of the molecular mechanisms that control invasive cellular behavior in general. Like the border cells, most tumor cells originate from within an epithelium and also frequently invade the surrounding tissue as small clusters, or cohorts of cells, rather than as individual cells (Nabeshima et al., 1999) .
The observation that the steroid hormone ecdysone can stimulate border cell migration, without any apparent effect on cell proliferation or differentiation could have signi®-cance for hormone-dependent human cancers, such as breast, ovarian, and prostate cancers. It is already known that steroid hormones such as estrogen promote the progression of these types of cancers to a highly invasive and metastatic state. In fact, the anti-estrogen tamoxifen can prevent metastasis and is a highly effective therapeutic agent against breast and ovarian cancers. It is clear that one effect of steroid hormones on cancer cells is to stimulate proliferation. However, the role of ecdysone in promoting border cell motility suggests that steroid hormones may promote metastasis directly by stimulating motility. In support of this hypothesis, breast cancer cells have been reported to respond to estrogen treatment by extending ®lopodia that then make E-cadherin mediated contacts with underlying cells (DePasquale, 1999) . In addition, the anti-estrogen raloxifene inhibits metastasis of PAIII adenocarcinoma cells in the rat, without effects on growth of the primary tumor or proliferation of the PAIII cells in vitro (Neubauer et al., 1995) .
The movement of border cells in response to an EGF receptor ligand is also reminiscent of breast cancer cells. Expression of the EGF receptor is frequently dramatically elevated in metastatic breast cancer cells, where EGF acts as both a mitogen and a chemoattractant. Thus at least two factors that regulate proliferation of cancer cells, steroids and EGF, also regulate motility. This is reminiscent of factors that regulate cell migration during mammalian development. For example, Steel Factor, which is the ligand for the c-Kit receptor tyrosine kinase, regulates proliferation, survival, and chemotaxis of multiple migratory cell types in the mammalian embryo. One reason why proliferation, survival, and migration are controlled by the same factor(s) during development might be to ensure that only those cells that migrate to the appropriate destination are able to survive and proliferate. This strategy could then prevent developmental abnormalities that might otherwise result from the proliferation of errant cells. This connection may then surface again in cancer cells that respond to growth factors and hormones in their environment with an increase in both proliferation and invasive behavior.
Future directions
A systematic genetic approach towards identifying the genes required for border cell migration is well underway. A variety of screening approaches is being applied and this is useful because each approach identi®es some genes but fails to identify others. The approaches that have been reported so far include screening for female sterility due to border cell migration defects, screening for suppression of slbo migration defects by over-expression of random genes, screening for border cell migration defects in mosaic clones, and testing of speci®c candidate genes. Since none of the screens has yet reached saturation, these approaches should continue to ®ll in the gaps in our understanding for some time to come. One important feature of the unbiased genetic approaches is the ability to discover mechanisms that were previously unanticipated, such as the role of steroid hormone signaling in border cell migration. The mechanisms regulating Rac and myosin activities remain largely mysterious in these cells and are fertile grounds for additional genetic approaches. In addition, it will be of interest to de®ne the components of the E-cadherin complexes in the border cells since they may be different in migrating cells and in stationary epithelial cells.
